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Introduction
It is known that infl ammations of 
the skin are accompanied by bacterial 
contamination and therefore require the 
use of prolonged antimicrobial action. 
This effect can be achieved by using 
external antimicrobial agents in the form 
of ointments, creams and gels. [1] In 
present among the large number of drugs 
proposed for treatment of acne the dosage 
form of surface action based on azelaic 
acid and benzoyl peroxide is stipulated. 
Azelaic acid (HOOC(CH2)7COOH) – the 
active pharmaceutical ingredient (API) 
of a famous cream called Skinoren® 20% 
(Schering) is the antibiotic drug, which 
is produced by the yeast Pityrosporum 
acne. It inhibits the growth of propionic 
bacteria and the formation of fatty acids 
contributing to the occurrence of acne. 
In turn the API of a drug called Ugresol 
10% (Pharmascience Inc., Canada), 
benzoyl peroxide (C6H5C(O)OO(O)
C6H5) effectively regulates the processes 
of keratinization in the sebaceous 
follicles, improves oxygenation of 
tissues, reduces the level of free fatty 
acids in the lipid tissues, and has 
antimicrobial effect, especially with 
regard to Propionibacterium acne and 
Staphylococcus epidermidis [2-10].
The research clarifi es the 
applicability of diperoxyazelaic acid as 
an active pharmaceutical ingredient in 
preparations of surface action regarding 
acne, which, unlike benzoyl peroxide, 
is not capable of radical decomposition, 
and therefore will not have the ability to 
enhance carcinogenesis by UV radiation.
The aim of the study was to conduct 
the comparative study of antimicrobial 
activity of the ointment on the basis 
of our proposed new substance – 
diperoxyazelaic acid (hereinafter both 
DPAA) (Fig. 1) and two European 
branded drugs – AkneStop 20% 
(Corporation "Arterium", Kyiv) and 
Ugresol Lotion 10% (Brij 30, disodium 
EDTA, carbomer 940) (Pharmascience 
Inc., Canada).
Polyethylene oxide (PEO) was 
chosen as the basis for ointments of 
diperoxyazelaic acid. This is the most 
common excipient of all known water-
soluble bases on Pharmacopoeias of the 
most part of the world. The advantages 
of PEO: satisfactory water solubility, the 
ability to dissolve the hydrophilic and 
hydrophobic drugs, well mixed with wax 
and glycerides to form stable pseudo-
emulsion well applied to the skin, does 
not prevent gas exchange and does 
not affect the activity of glands, weak 
bactericidal effect due to the presence 
of primary osmotically active hydroxyl 
groups. All PEO base are neutral, non-
toxic, physiologically neutral, suitable 
for long-term use, not damaging the 
skin, easy to release drugs, not being 
the environment for the development of 
microfl ora. Being actively mixed with 
other substances, these bases can be 
used for all soluble and most of water-
insoluble drugs.
Mechanism of action of peroxyacids 
is the following. Compounds with active 
oxygen used in the composition of 
disinfectants and antimicrobial agents, 
represent hydrogen peroxide, perborate, 
persulfate, percarbonate etc., as well 
as peracids, and hydrogen peroxide 
oxidation obtaining carboxylic acids. 
They can be seen as a replacement 
product or just the two hydrogen atoms 
in a molecule of hydrogen peroxide to 
acyl groups.
Compounds with active oxygen 
belong to the group of disinfectant 
oxidants. Under the infl uence of the 
Lane oxide group there goes oxide 
inactivation of lipids and proteins, 
essential elements of microorganisms, 
bacterial cytoplasmic membrane and 
membranes of the spore forms of 
bacteria. Lipid peroxidation, most 
pronounced on unsaturated fatty acids, 
leads to a decrease of hydrophobicity 
and increase of membrane permeability. 
And membrane proteins are changing 
through the formation of protein-lipid 
complexes, oxidation and denaturation 
of proteins containing -SH group and 
the possible formation of cross-links 
in amino (NH2). Inhibition of redox 
enzymes leads to respiratory failure 
of microbial cells. Study of oxygen-
containing drugs on the cells of bacteria 
and spores of bacillus showed that all 
tested microorganisms lose protein 
up to 90%; DNA – up to 30-50%, the 
RNA – up to 30%, and spore forms also 
lose 25% of dipicolinic acid. Equally 
signifi cant washout of intracellular 
components demonstrates the rapid 
violation of integrity of bacterial cells 
and spores [11-12].
Materials and methods
Diperoxyazelaic acid was 
synthesized by a known method of 
Swern [13] according to the scheme (in 
the present sulphuric acid): Fig. 1. Structure of diperoxyazelaic acid
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НО(О)С(СН2)7С(О)ОН+Н2О2 = 
НОО(О)С(СН2)7С(О)ООН + H2O.
Diperoxyazelaic acid (nonanebis 
(peroxoic acid), T mp. + 90-90,5ºC (with 
decomp.), the content of active oxygen 
species (AOC) 14,2%; рКа1=8,08, 
рКа2=9,19.
To confi rm the stability of DPAA, 
one sample was kept in a self-sealing 
bag at room temperature (30-35 °C). The 
active oxygen content of the sample was 
determined by iodometric titration after 
every 10-15 days. It was found that it 
retains its active oxygen content over a 
period of 50 days (14.2-14.1%). There 
were no changes observed in the physical 
appearance, too. This confi rms the 
stability of DPAA at room temperature. 
An ointment composition: 0.8-1.2 wt. 
% DPAA; Poly(ethylene oxide), MW 400 
(PEO 400) (Specif. 2483 007 71150986 
2006), 78,0-79,4 wt.%, Poly(ethylene 
oxide), MW 1500 (PEO-1500) 
(Specif. 2483-008-71150986-2006), 
20,19-19,38 wt.%; disodium EDTA 
(0,1-0,02 wt.%). The content of DPAA 
ointment is determined experimentally. 
Reduction of its content in the 
composition of the drug leads to a marked 
reduction of antimicrobial activity. The 
composition of water-soluble hydrophilic 
ointment base with the specifi ed content 
PEO 400, PEO-1500, disodium EDTA 
was also chosen experimentally. Due to 
optimal components this framework is 
the most appropriate, since it promotes 
optimal release of active substances, 
chemically indifferent with respect to 
the drug and is convenient in terms of 
technology of ointments production.
The study of antimicrobial activity of 
the objects carried by agar diffusion was 
based on the ability of active substances 
to diffuse in the culture medium of the 
previously inoculated microorganisms. 
According to WHO recommendations we 
used the following museum strains for 
assessment of antibacterial and antifungal 
activity of drugs as the test cultures: 
gram-negative bacillus Escherichia coli 
ATCC 25922, Pseudomonas aeruginosa 
ATCC 27853, Gram-positive cocci 
Staphylococcus aureus ATCC 25923 and 
spore-forming bacillus Bacillus subtilis 
ATCC 6633, yeast fungi Candida albicans 
ATCC 653/885, and clinical isolates: 
Candida tropicalis, Candida krusei, 
Candida glabrata. In the experiment we 
used daily suspension of microorganisms 
in saline. Microbial load was 1 · 107 
colony forming units in 1 ml of the nutrient 
medium [14,15].
Antimicrobial activity of 1% ointment 
DPAA was studied in 1 day 2 weeks and 
1 month after preparation. The results 
determine the antimicrobial activity 
of 1% ointment DPAA. Comparison 
of preparations is presented in 
Table 1. It shows that 1% ointment DPAA 
manifests antimicrobial action with 
respect to C. albicans and C. tropicalis 
level comparator AkneStop 20%. 
While antibiotic ointment revealed the 
effect of DPAA against Gram-negative 
(E. coli, Ps. Aeruginosa) and gram-
positive bacteria (St. aureus, B. subtilis) 
strongly exceeding the effect of other 
investigated drugs. As seen from the 
data in Table 1, ointment based of DPAA 
revealed high antimicrobial activity 
in relation to the St. aureus, E. coli, 
Ps. aeruginosa and C. albicans, less 
pronounced – to B. subtilis, C. tropscalis, 
C. krusei and C. glabrata.
Consequently, studies have shown 
that the new DPAA ointments based on 
hydrophilic matrix reveal suffi ciently high 
antimicrobial activity (which is dominated 
by European brands), and therefore the 
further in-depth research promising.
Conclusions
The diperoxyazelaic acid 
was synthesised. Ointment on the 
polyethylenoxide basis containing 1% 
diperoxyazelaic acid was obtained. The 
antimicrobial effects of the ointment and 
branded drugs Acne Stop and Ugresol 
have been examined in comparative 
perspective. The shelf life of creams was 
clarifi ed, and the conclusion was made 
about the prospects for further in-depth 
study of the issue of its application as an 
extemporal dosage form.
Tab. 1. 
The results determine the antimicrobial activity
Testculture Zones of growth inhibition test cultures 
mm (n = 3)
Ointment based DPAA 1% After 1 month of storage
Staphylococcus aureus 45,4±1,3
Escherichia coli 45,0±0,4
Pseudomonas aeruginosa 38,8±2,6
Bacillus subtilis 22,7±2,8
Candida tropscalis 23,7±1,4
Candida albicans 31,3±3,7
Candida krusei 21,5±1,5
Candida glabrata 14,8±1,7
Aknestop 20%
Staphylococcus aureus 35,1±0,4
Escherichia coli 21,3±0,7
Pseudomonas aeruginosa 29,0±1,2
Bacillus subtilis 15,0±0,7
Candida tropscalis 22,3±0,3
Candida albicans 27,1±1,1
Candida krusei 22,4±0,6
Candida glabrata 9,0±0,5
Ugresol 10%
Staphylococcus aureus 15,1±1,2
Escherichia coli 12,8±1,3
Pseudomonas aeruginosa -
Bacillus subtilis 16,1±1,2
Candida tropscalis 17,7±0,5
Candida albicans 24,5±0,5
Candida krusei -
Candida glabrata -
Note. “-” - A zone of stunted growth of microorganisms available.
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